Specific tests for Alzheimer’s disease (AD) diagnosis are currently unavailable, despite AD being the leading cause of dementia. One hallmark of AD progression is the aggregation of tau proteins into paired helical filaments and neurofibrillary tangles, which is accelerated by the hyperphosphorylation of Tau proteins. However, the mechanism by which the hyperphosphorylated tau accelerates protein aggregation is not completely understood. Furthermore, detecting and disrupting such aggregated forms through the blood-brain barrier (BBB) remains a significant bottleneck in developing AD diagnostics and therapeutics. At the same time, quantum dots (QDs) have shown tremendous potential in penetrating the BBB to diagnose brain cancer, as well as detecting and disrupting protein aggregates in other neurodegenerative diseases such as Parkinson’s disease. QDs are an attractive diagnostic material due to their fluorescence-emitting capabilities, nanoscale size that allows penetration of the BBB, chemical stability, solubility, and facile synthesis. However, QDs have not yet been assessed for their ability to detect and disrupt hyperphosphorylated tau tangles. Hence, the aims of this project are two-fold: 1) to unravel the mechanisms and energetic barriers of normal and hyperphosphorylated tau protein aggregation by building three-dimensional atomistic models of aggregated structures and performing classical and enhanced sampling molecular dynamics simulations on these models; 2) to predict the potential of QDs in binding to and disrupting hyperphosphorylated tau tangles though polarized ligand docking and free-energy calculations. Upon identification of potential QD-binding signatures, these QDs will be synthesized and tested in vitro and in vivo through collaborative efforts with the goal of translating this work into clinical diagnostic applications for AD in the future.
Figure 1. Microtubule-associated protein tau (MAPT) functions in the healthy brain (left) and a brain with Alzheimer’s disease (AD) (right). Self-association and excessive post-translational modifications of Tau proteins result in the formation of neurofibrillary tangles and cause neurodegeneration in AD patients. Targeting the tau aggregates using Quantum Dots could help develop potential diagnostics and/or therapeutics for AD.
Related Content

Quantum Material Multilayer Photonic Devices and Network
Summary Realizing highly integrated quantum photonic devices on a chip can enable new opportunities for photonic quantum computation. In this project, we explore heterostructures of stacked two-dimensional (2D) materials, such transition metal dichalcogenides (TMDC) or graphene, combined with optical microcavities as a platform for such devices. 2D materials are extremely thin and flexible, and have […]
December 12, 2019

A Reformulation of Quantum Game Theory
Summary Classical game theory – conducted at the interface between economics and computer science – has found applications in topics ranging from networking and security to online markets. Despite over 20 years of research into connections between game theory and quantum information, we have yet to see any significant implications of quantum information when applied […]
April 1, 2020

Quantum Information Processing with Molecular Lattices
The aim of the work is to develop theoretical tools to simulate and predict the behaviour of a one-dimensional chain of trapped dipolar molecules and to study the nature of entanglement as a design resource.
June 1, 2017

On-Chip Microwave-Optical Quantum Interface
Summary In this project we develop a quantum interface between microwave and optical photons as a key enabling technology of a hybrid quantum network. In such a network, the robust optical photons carry quantum information through optical fibres over long distances, while superconducting microwave circuits protected from thermal photon noise by the low temperature […]
October 29, 2018